Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Cancer|August 12, 2014
Docetaxel plus oral metronomic cyclophosphamide: a phase II study with pharmacodynamic and pharmacogenetic analyses in castration-resistant prostate cancer patientsLisa Derosa, Luca Galli, Paola Orlandi, et al.
Future Oncology (London, England)|October 6, 2015
Docetaxel rechallenge in metastatic castration-resistant prostate cancer: any place in the modern treatment scenario? An intention to treat evaluationSergio Bracarda, Claudia Caserta, Luca Galli, et al.
Surgical Oncology|September 1, 2020
Renal cell carcinoma: The role of radical surgery on different patterns of local or distant recurrenceGregorio Di Franco, Matteo Palmeri, Andrea Sbrana, et al.
Frontiers in Oncology|December 13, 2021
Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)Marco Maruzzo, Elena Verzoni, Maria Giuseppa Vitale, et al.
BJU International|May 6, 2019
Androgen receptor (AR) splice variant 7 and full-length AR expression is associated with clinical outcome: a translational study in patients with castrate-resistant prostate cancerMarzia Del Re, Stefania Crucitta, Andrea Sbrana, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|January 27, 2023
Surgical treatment of recurrent retroperitoneal sarcoma in its different patterns: A 15-years' two-centers experienceSimone Guadagni, Andrea Peri, Matteo Palmeri, et al.
Journal of Translational Medicine|August 16, 2022
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIsMarzia Del Re, Stefania Crucitta, Federico Paolieri, et al.
Oncotarget|September 5, 2015
Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patientsAnna Solini, Vittorio Simeon, Lisa Derosa, et al.
Vaccines|June 24, 2022
Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective AnalysisAmedeo Nuzzo, Simona Manacorda, Enrico Sammarco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2009
Clinical and pharmacodynamic evaluation of metronomic cyclophosphamide, celecoxib, and dexamethasone in advanced hormone-refractory prostate cancerAndrea Fontana, Luca Galli, Anna Fioravanti, et al.
Pageof 15